The CNS Specific Antisense Oligonucleotide market is witnessing remarkable growth driven by advances in targeted therapies for neurological disorders. Recent innovations and expanding clinical applications underscore significant market potential over the coming years. https://hallbook.com.br/blogs/834056/CNS-Specific-Antisense-Oligonucleotide-Market-Size-and-Trends-Driving-Rapid